Managing raw material changes in cell & gene therapy: ensuring compliance and consistency
J King-Hart, M Mendicino, K Kime et al.
Enabling scalable CAR-T therapies with next-gen animal component-free T cell media
Pedro Azevedo Da Silva Couto, Rukmini Ladi
Ensuring success in AAV scale-up: key data from case studies across four serotypes (APAC)
K Cybulski, K Burrell, A Low (Joining for Q&A)
Non-viral, large-scale delivery of gene editing tools for T cell manufacturing
Stefanie Müthel, Andrea Toell
Viral vector manufacturing: optimization through culture, QC and regulatory standards
J Cody, M Sharma, G Gayosa